FDA Registration (FEI# 3017371366)
FDA Inspection date - 1/23/2023
Florida Department of Business & Professional Regulation, Division of Drugs, Devices & Cosmetics facility inspection date - 10/13/2022
Redefining Regenerative Medicine
The future of medicine is regenerative.
We hope to shape the future of regenerative therapies through clinical research, product development, and manufacturing.
Who we are:
Neobiosis is a biotechnology company focused on the development and manufacturing of innovative perinatal products for research and clinical trials. Our goal is simple: to help redefine the field of regenerative medicine through regenerative science and shape the future of this fledgling industry through meaningful partnerships and collaborations. We are uniquely positioned to help usher in this new era of medicine, which focuses on the potential of perinatal birth tissues including cells, EVs and matrix. Neobiosis is owned and operated by physicians and scientists.
Leveraging the Building Blocks of Life to Regenerate the Body.
The growth factors and regenerative compounds present in the womb give rise to incredible growth and tissue development. We’re committed to exploring how they can help us heal and regenerate tissues by empowering clinical research.
Amniotic fluid, placenta, umbilical cord, and other materials that are typically overlooked and discarded after a healthy birth contain large amounts of proteins, cellular membranes, and other fundamental building blocks of healing and regeneration. Our proprietary technology enables us to extract these cells, EVs, and matrix. We are building delivery methods for these powerful regenerative agents and rigorously researching their impact.
Product Development and Manufacturing Services
As a CDMO, we help determine the best developmental and manufacturing path for your product in preparation for your clinical trial.
NEOBIOSIS is a Contract Development & Manufacturing Organization (CDMO) with an operating research and development (R&D) program located at the University of Florida, Sid Martin Innovate Biotechnology Center — the #1 biotech incubator in the world – and two dedicated tissue processing cleanrooms, which will operate under Current Good Manufacturing Practice (CGMP) standards, located in downtown Gainesville, Florida.
Our Founder
Ian A. White, M.S., Ph.D.
Founder, CEO & Chief Scientific Officer
Dr. White is an expert in the field of regenerative medicine and stem cell biology with over 20 years’ experience working in academia and industry. His academic career includes field defining work at institutions such as Dartmouth, Harvard, and Cornell. At Neobiosis, Dr. White translates his academic research into tangible solutions for the problems of aging and tissue regeneration.
Heterochronic Parabiosis
The Foundation of our Work
Hetero
=
Different
Chronic
=
Age
Para
=
Together
Biosis
=
Living
The core idea is the body has all the tools necessary to repair and regenerate, and this ability is transferable between individuals. This biological process was successfully demonstrated by transferring young tissues, cells and EVs to older laboratory subjects.